[HTML][HTML] Chemopreventive Effects of Onosma mutabilis against Azoxymethane-Induced Colon Cancer in Rats via Amendment of Bax/Bcl-2 and NF-κB Signaling …
Onosma species (Boraginaceae) are well known as medicinal plants due to their wide range
of pharmaceutical potential. The present study aims to investigate the anticancer (in vitro) …
of pharmaceutical potential. The present study aims to investigate the anticancer (in vitro) …
Pinostrobin attenuates azoxymethane-induced colorectal cytotoxicity in rats through augmentation of apoptotic Bax/Bcl-2 proteins and antioxidants
B Ali Abed Wahab, N Ain Salehen… - SAGE Open …, 2023 - journals.sagepub.com
Objectives: Pinostrobin (5-hydroxy-7-methoxyflavanone; PN) is a natural active ingredient
with numerous biological activities extensively utilized in tumour chemotherapy. The present …
with numerous biological activities extensively utilized in tumour chemotherapy. The present …
[PDF][PDF] Colonoscopies in Australia—how much does the National Bowel Cancer Screening Program contribute to colonoscopy use
J Worthington, E He, JB Lew, J St John, C Horn… - Public Health Res …, 2023 - phrp.com.au
Objectives and importance of study: Colorectal cancer (CRC) is Australia's fourth most
commonly diagnosed cancer. CRC screening is an effective intervention to reduce this …
commonly diagnosed cancer. CRC screening is an effective intervention to reduce this …
[HTML][HTML] Pinostrobin attenuates azoxymethane-induced colorectal cytotoxicity in rats through augmentation of apoptotic Bax/Bcl-2 proteins and antioxidants
BAA Wahab, NA Salehen, MA Abdulla… - SAGE Open …, 2023 - ncbi.nlm.nih.gov
Objectives: Pinostrobin (5-hydroxy-7-methoxyflavanone; PN) is a natural active ingredient
with numerous biological activities extensively utilized in tumour chemotherapy. The present …
with numerous biological activities extensively utilized in tumour chemotherapy. The present …
[HTML][HTML] Associations of advanced age with comorbidity, stage and primary subsite as contributors to mortality from colorectal cancer
Background Although survival from colorectal cancer (CRC) has improved substantially in
recent decades, people with advanced age still have a high likelihood of mortality from this …
recent decades, people with advanced age still have a high likelihood of mortality from this …
[HTML][HTML] COVID-related disruptions to colorectal cancer screening, diagnosis, and treatment could increase cancer Burden in Australia and Canada: A modelling study
COVID-19 disrupted cancer control worldwide, impacting preventative screening,
diagnoses, and treatment services. This modelling study estimates the impact of disruptions …
diagnoses, and treatment services. This modelling study estimates the impact of disruptions …
Effects of quality nursing on the surgical site wound infection after colostomy in patients with colorectal cancer: A meta‐analysis
C Liu, P Huang, H Hu, GW Chen… - International Wound …, 2024 - Wiley Online Library
To systematically evaluate the effects of quality nursing interventions on surgical site wound
infections (SSWI), length of stay in the hospital and postoperative complications in patients …
infections (SSWI), length of stay in the hospital and postoperative complications in patients …
[HTML][HTML] Experiences of colorectal cancer survivors in returning to primary coordinated healthcare following treatment
C Rutherford, B Kim, K White, C Ostroff… - Australian Journal of …, 2023 - CSIRO Publishing
Background Advances in screening and treatments for colorectal cancer (CRC) have
improved survival rates, leading to a large population of CRC survivors. Treatment for CRC …
improved survival rates, leading to a large population of CRC survivors. Treatment for CRC …
Molecular biomarkers in type 2 diabetes and colorectal cancer
E Alvandi - 2023 - researchdirect.westernsydney.edu …
Abstract Globally, Type 2 Diabetes (T2D) and Colorectal Cancer (CRC) are among the most
prevalent metabolic diseases and cancers, respectively. T2D is a progressive disease …
prevalent metabolic diseases and cancers, respectively. T2D is a progressive disease …